通过临床注册与Medicare理赔链接实现腹壁疝修补术后长期随访
本研究将ACHQC注册中接受腹壁疝修补术的老年或Medicare患者(2014-2019)与Medicare理赔数据链接,评估长期随访可行性和疝复发率。69%患者链接成功,中位随访从32天增至778天,4年再手术率10.8%,因补片类型而异。
要点
- 注册与理赔链接使中位随访从32天延长至778天。
- 4年再手术率为10.8%,生物补片组达19.3%。
- 链接方法可行,有助于补片上市后监测。
核心结论
- 将疾病特异性注册数据与Medicare理赔数据链接可延长腹壁疝修补术后的长期随访,并改善卫生服务研究和疝补片上市后监测。
研究设计与样本
- 观察性队列研究,链接ACHQC注册中年龄≥65岁或拥有Medicare且接受腹壁疝修补术(2014-2019)的患者与Medicare按服务付费理赔数据,采用序贯链接算法。
主要发现
- 10,757例ACHQC患者中7,418例(69%)成功链接至Medicare理赔数据。
- 中位随访从32天(IQR 18-83天)增至778天(IQR 383-1216天)(P<0.001)。
- 链接患者中位年龄69岁(IQR 65-74),女性48%,中位BMI 30 kg/m2(IQR 27-35)。
- 大多数为切口疝(74%)或脐疝(18%)修补,清洁手术占83%;平均疝宽度5 cm(IQR 3-10),31%为复发修补。
- 开放手术(67%)和机器人手术(16%)最常见;39%行肌筋膜松解,筋膜闭合率91%;88%使用补片(91%永久合成补片,4%生物补片,4%可吸收合成补片)。
临床怎么用
- 对于老年或Medicare腹壁疝修补患者,可考虑利用注册-理赔链接获取长期随访数据。
- 解读再手术率时需考虑补片类型差异,生物补片组再手术率较高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the feasibility of linking short-term clinical data from a disease specific registry with longitudinal Medicare claims to improve long-term follow-up and examine hernia recurrence rates. BACKGROUND: Disease-specific registries provide rich perioperative data on ventral hernia repairs (VHR), but long-term follow-up remains challenging. METHODS: This observational cohort study linked patients in the Abdominal Core Health Quality Collaborative (ACHQC) aged≥65 or with Medicare who underwent VHR (2014-2019) to Medicare Fee-for-service claims using a sequential linkage algorithm. Follow-up duration and recurrence rates, defined as reoperation for hernia recurrence (RHR), were analyzed. RESULTS: Of 10,757 ACHQC patients, 7,418 (69%) were successfully linked to Medicare claims data. Median follow-up increased from 32 days (IQR 18-83 d) to 778 days (IQR 383-1216) (P<0.001). Linked patients had a median age of 69 years (IQR 65-74), 48% women and median BMI of 30 kg/m2 (IQR 27-35). Most underwent incisional (74%) or umbilical (18%) repair in clean (83%) situations. Mean hernia width was 5 cm (IQR 3-10) with 31% undergoing recurrent repair. Open (67%) and robotic (16%) approaches were most common. Myofascial release was performed in 39% with a fascial closure rate of 91%. Mesh was used in 88% (91% permanent synthetic mesh, 4% biologic, 4% resorbable synthetic). At 4 years, estimated RHR was 10.8%, varied by mesh type: biologic 19.3%, resorbable synthetic 16.4%, no mesh 11.1%, permanent synthetic 10.1%. CONCLUSION: Linking clinical registry data with Medicare claims data can increase long-term follow-up after VHR and improve health services research and post market surveillance of hernia mesh.
引用
- Varone A, Zheng X, Mao J, et al. Enabling Long Term Follow up After Ventral Hernia Repair Through Clinical Registry and Medicare Claims Linkage. Ann Surg. 2025. PMID: 40415687. doi:10.1097/SLA.0000000000006766
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。